Baycol

By 2001, the evidence became impossible to ignore. Internal documents later suggested that Bayer may have been aware of these risks as early as the drug's US approval in 1997. On , Bayer voluntarily withdrew Baycol from the global market following reports linking it to 31 deaths in the U.S. and dozens more worldwide. Study: Baycol risks greaterthan believed - NBC News

The story of (cerivastatin) is a cautionary tale of a medical breakthrough that turned into a pharmaceutical crisis, ultimately leading to one of the most significant drug recalls in history. The Rise of a "Blockbuster" baycol

As Baycol’s popularity grew, so did reports of a rare but devastating side effect: . This condition causes muscle tissue to break down and leak into the bloodstream, which can lead to severe muscle pain, kidney failure, and death. By 2001, the evidence became impossible to ignore

While all statins carry a minor risk of this condition, Baycol’s risk was found to be significantly higher. The danger escalated dramatically when the drug was taken in combination with , another cholesterol medication; in these cases, the risk of muscle destruction was up to 10 times higher than with other statins. The Fall and Recall and dozens more worldwide